The Hidden Costs of Cancer Care: Medical Debt and Insurance Challenges
In 2020, Jeni Rae Peters, a mental health counselor in Rapid City, South Dakota, faced significant financial challenges despite having employer-provided health insurance. Diagnosed with stage 2 breast cancer, she continued working through her treatment to maintain her health coverage. However, switching jobs led to a reset of her insurance benefits, including deductible limits, which compounded her financial strain. Peters accumulated at least $30,000 in medical debt due to repeated surgeries, chemotherapy, and additional injuries.
A 2024 report by the American Cancer Society Cancer Action Network revealed that nearly half of cancer patients and survivors incurred medical debt, even with insurance. Most were enrolled in high-deductible plans, highlighting that insurance often fails to shield against significant financial burdens. Notably, the study found that 98% of insured individuals encountered debt challenges, underscoring a systemic issue within health insurance coverage.
The insurance model typically includes deductibles, copayments, coinsurance, and annual limits designed to moderate usage. For patients with chronic conditions, these features often lead to ongoing financial burdens. Deductibles and out-of-pocket maximums reset annually, forcing patients to meet high financial thresholds repeatedly. In 2023, under the Affordable Care Act, the individual out-of-pocket cap reached $10,600, representing a substantial, recurring financial obligation.
Cancer patients with medical debt face severe repercussions. These include an inability to save (60%), damaged credit scores (49%), harassment from creditors (46%), and considerations or filings for bankruptcy (18% and 6%, respectively). These strains contribute to housing instability and are linked to higher mortality rates among bankrupt patients, illustrating the profound impact of such financial obligations.
Within the insurance industry, there's a prevailing view that patient financial contributions foster cost-awareness. Nonetheless, these strategies can penalize those needing essential treatments, as out-of-pocket expenses remain significant before insurance kicks in. This reduces insurer liabilities on claims but places heavy financial burdens on policyholders.
Future discussions will continue to examine topics like the implications of coverage purchased through ACA marketplaces and the role of employers in shaping employee healthcare financial responsibilities. This ongoing examination aims to highlight systemic issues and explore potential remedies in the current insurance landscape, addressing both patient and insurer perspectives.